Predicting symptom onset in RIS using combined biomarker approaches
Автор: VJNeurology
Загружено: 2026-02-12
Просмотров: 5
Описание:
Raphael Schneider, MD, PhD, FRCPC, CIP, St. Michael’s Hospital, Toronto, Canada, discusses the importance of considering multiple biomarkers to predict the risk of a person with radiologically isolated syndrome (RIS) developing symptoms. Dr Schneider notes that his center is working on combining data from protein biomarkers and imaging to create a more accurate predictor of future risk. This interview is part of our coverage of the 11th Annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
